Exicure (XCUR) Short-term Investments (2019 - 2022)
Exicure (XCUR) reported Short-term Investments of $997000.0 for Q2 2022, down 92.6% on a YoY basis from $13.5 million in Q2 2021, and down 60.02% quarter-over-quarter from $2.5 million in Q1 2022.
Exicure (XCUR) Short-term Investments (2019 - 2022) Analysis & Trends
Exicure has reported Short-term Investments for 4 years, with the latest figure at $997000.0 in Q2 2022.
- For the quarter ending Q2 2022, Short-term Investments fell 92.6% year-over-year to $997000.0; the trailing twelve-month figure through Jun 2022 stood at $997000.0 (down 92.6% YoY), and the FY2021 full-year result was $4.5 million, down 90.79% from the prior year.
- Short-term Investments for Q2 2022 stood at $997000.0, down from $2.5 million in the prior quarter.
- The five-year high for Short-term Investments was $74.2 million in Q1 2020, with the low at $997000.0 in Q2 2022.
- Historically, Short-term Investments has averaged $34.6 million across 4 years, with a median of $33.1 million in 2021.
- Annual changes were most pronounced in 2020 — Short-term Investments decreased 21.67% — and 2022, when it plunged 92.6%.
- Exicure's Short-term Investments stood at $62.3 million in 2019, then declined by 21.67% to $48.8 million in 2020, then plunged by 90.79% to $4.5 million in 2021, then slumped by 77.83% to $997000.0 in 2022.
- The last three Short-term Investments figures came in at $997000.0 (Q2 2022), $2.5 million (Q1 2022), and $4.5 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 997,000.00 |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 4.50 Mn |
| Sep 30, 2021 | 8.95 Mn |
| Jun 30, 2021 | 13.47 Mn |
| Mar 31, 2021 | 33.14 Mn |
| Dec 31, 2020 | 48.82 Mn |
| Sep 30, 2020 | 62.62 Mn |
| Jun 30, 2020 | 68.58 Mn |
| Mar 31, 2020 | 74.22 Mn |
| Dec 31, 2019 | 62.33 Mn |